Collegium Pharmaceutical
COLL
COLL
193 hedge funds and large institutions have $1.24B invested in Collegium Pharmaceutical in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 58 increasing their positions, 77 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
25% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 77
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
86% less call options, than puts
Call options by funds: $305K | Put options by funds: $2.15M
Holders
193
Holding in Top 10
1
Calls
$305K
Puts
$2.15M
Top Buyers
| 1 | +$43.6M | |
| 2 | +$27.2M | |
| 3 | +$9.76M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$8.68M |
| 5 |
Renaissance Technologies
New York
|
+$6.53M |
Top Sellers
| 1 | -$14M | |
| 2 | -$12.8M | |
| 3 | -$7.78M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$7.7M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$6.5M |